Skip to main content
Supplement ScienceSupplementScience

Types of DIM (Diindolylmethane): Forms & Bioavailability

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Forms Comparison

FormBioavailabilityBest For
BioResponse DIM (microencapsulated)High (absorption-enhanced formulation)Best form — microencapsulation provides 50-150x better absorption than crystalline DIM; used in clinical trials
Crystalline DIMVery Low (poor solubility, <10% absorption)Budget option — very poorly absorbed; requires much higher doses for equivalent effects
Indole-3-Carbinol (I3C) — PrecursorVariable (acid-dependent conversion to DIM)Precursor approach — converts to DIM in stomach acid, but conversion is unpredictable and I3C has its own activity

BioResponse DIM (microencapsulated)

Bioavailability: High (absorption-enhanced formulation). Best for: Best form — microencapsulation provides 50-150x better absorption than crystalline DIM; used in clinical trials.

Crystalline DIM

Bioavailability: Very Low (poor solubility, <10% absorption). Best for: Budget option — very poorly absorbed; requires much higher doses for equivalent effects.

Indole-3-Carbinol (I3C) — Precursor

Bioavailability: Variable (acid-dependent conversion to DIM). Best for: Precursor approach — converts to DIM in stomach acid, but conversion is unpredictable and I3C has its own activity.

Find the best DIM (Diindolylmethane) for your needs
Ranked by form, bioavailability, and value
Full DIM (Diindolylmethane) Guide

References

  1. Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL, Bjeldanes LF (2004). Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutrition and Cancer. DOI PubMed
  2. Bjeldanes LF, Kim JY, Grose KR, Bartholomew JC, Bradfield CA (1991). Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proceedings of the National Academy of Sciences. DOI PubMed
  3. Reed GA, Sunega JM, Sullivan DK, Gray JC, Mayo MS, Crowell JA, Hurwitz A (2005). Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3'-diindolylmethane in healthy subjects. Cancer Epidemiology, Biomarkers & Prevention. DOI PubMed
  4. Le HT, Schaldach CM, Bheldanes LF, Firestone GL (2003). Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells. Journal of Biological Chemistry. DOI PubMed